Comparison of the dose-response pharmacodynamic profiles of detemir and glargine in severely obese patients with type 2 diabetes: A single-blind, randomised cross-over trial
Bilz S, Flückiger M, Meienberg F, Falconnier C, Keller U, Puder J. Comparison of the dose-response pharmacodynamic profiles of detemir and glargine in severely obese patients with type 2 diabetes: A single-blind, randomised cross-over trial. PloS one 2018; 13:e0202007.
16.08.2018
Comparison of the dose-response pharmacodynamic profiles of detemir and glargine in severely obese patients with type 2 diabetes: A single-blind, randomised cross-over trial
16.08.2018
PloS one 2018; 13:e0202007
Bilz Stefan, Flückiger Miriam, Meienberg Fabian, Falconnier Claudine, Keller Ulrich, Puder Jardena J
Weiter
